Immunity and inflammation in atherosclerosis - no longer just a theory
Video navigation menu
- A brief historical overview 0:38
- Basis of CANTOS and beyond 2:55
- Who set the athero aflame? 5:57
- The focus of this symposium 6:50
This introductory lecture by Peter Libby is part of a series titled "Inflammation: The next therapeutic frontier in targeting cardiovascular risk". This series consists of an introduction, three lectures and a discussion in which four experts in this field will bring you up to date on the role of inflammation in atherosclerosis and how to translate findings from science and clinical trials into practice.
Peter Libby is a cardiovascular medicine specialist at Brigham and Women’s Hospital and the Mallinckrodt Professor of Medicine at Harvard Medical School.
This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.
Funding for this educational program was provided by an unrestricted educational grant received from Novo Nordisk A/S.